Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Urinary Bladder Neoplasms 2 Rectal Neoplasms 2 Neoplasms 2 Stomach Neoplasms 1 Post-operative Ileus 1 Pancreatic Neoplasms 1 Pancreatic Cyst 1 Lung Neoplasms 1 Gallbladder Neoplasms 1 Disease 1 Colorectal Neoplasms 1 Colonic Polyps 1 Cholangiocarcinoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Advanced Gastric Carcinoma 1

Interventions

Carboplatin 779 Pemetrexed 606 Cisplatin 543 Paclitaxel 490 pembrolizumab 461 Docetaxel 440 Gemcitabine 328 Erlotinib Hydrochloride 307 Radiotherapy 255 Nivolumab 244 Bevacizumab 233 osimertinib 177 Drug Therapy 164 durvalumab 157 atezolizumab 135 Gefitinib 134 Radiosurgery 131 Vinorelbine 111 Cetuximab 97 130-nm albumin-bound paclitaxel 93 Ipilimumab 86 Magnetic Resonance Spectroscopy 83 Taxes 79 Surgical Procedures, Operative 74 Afatinib 68 Albumin-Bound Paclitaxel 66 Specimen Handling 61 Etoposide 61 Cyclophosphamide 60 tislelizumab 59

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Non-Small-Cell Lung × Defecation × Clear all

NCT05736029 2023-02-21

PROPHETIC

OncoHost Ltd.

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡